Annual CFI
-$6.37 B
-$2.84 B-80.40%
31 December 2023
Summary:
Novo Nordisk A/S annual cash flow from investing activities is currently -$6.37 billion, with the most recent change of -$2.84 billion (-80.40%) on 31 December 2023. During the last 3 years, it has fallen by -$2.93 billion (-85.37%). NVO annual CFI is now -23394.03% below its all-time high of -$27.12 million, reached on 31 December 1995.NVO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$3.13 B
-$133.84 M-4.47%
30 September 2024
Summary:
Novo Nordisk A/S quarterly cash flow from investing activities is currently -$3.13 billion, with the most recent change of -$133.84 million (-4.47%) on 30 September 2024. Over the past year, it has dropped by -$1.20 billion (-62.08%). NVO quarterly CFI is now -643.44% below its all-time high of $576.22 million, reached on 31 March 2024.NVO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$7.66 B
-$1.20 B-18.55%
30 September 2024
Summary:
Novo Nordisk A/S TTM cash flow from investing activities is currently -$7.66 billion, with the most recent change of -$1.20 billion (-18.55%) on 30 September 2024. Over the past year, it has dropped by -$1.37 billion (-21.77%). NVO TTM CFI is now -8694.12% below its all-time high of $89.19 million, reached on 31 March 2004.NVO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.4% | -62.1% | -21.8% |
| 3 y3 years | -85.4% | -339.6% | -108.1% |
| 5 y5 years | -233.0% | -782.2% | -302.3% |
NVO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -85.4% | at low | -643.4% | +4.7% | -117.0% | at low |
| 5 y | 5 years | -269.3% | at low | -643.4% | +4.7% | -464.8% | at low |
| alltime | all time | <-9999.0% | at low | -643.4% | +4.7% | -8694.1% | at low |
Novo Nordisk A/S Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.13 B(+4.5%) | -$7.66 B(+18.6%) |
| June 2024 | - | -$3.00 B(-620.2%) | -$6.47 B(+33.6%) |
| Mar 2024 | - | $576.22 M(-127.3%) | -$4.84 B(-24.1%) |
| Dec 2023 | -$6.37 B(+80.4%) | -$2.11 B(+9.3%) | -$6.37 B(+1.2%) |
| Sept 2023 | - | -$1.93 B(+41.0%) | -$6.29 B(+26.2%) |
| June 2023 | - | -$1.37 B(+42.9%) | -$4.99 B(+18.6%) |
| Mar 2023 | - | -$958.59 M(-52.9%) | -$4.20 B(+19.0%) |
| Dec 2022 | -$3.53 B(-29.8%) | -$2.03 B(+225.9%) | -$3.53 B(-26.1%) |
| Sept 2022 | - | -$624.14 M(+6.4%) | -$4.78 B(-1.8%) |
| June 2022 | - | -$586.61 M(+103.9%) | -$4.87 B(+2.5%) |
| Mar 2022 | - | -$287.67 M(-91.2%) | -$4.75 B(-5.5%) |
| Dec 2021 | -$5.03 B(+46.3%) | -$3.28 B(+361.1%) | -$5.03 B(+36.5%) |
| Sept 2021 | - | -$712.41 M(+52.4%) | -$3.68 B(-6.9%) |
| June 2021 | - | -$467.55 M(-17.1%) | -$3.96 B(+7.2%) |
| Mar 2021 | - | -$564.29 M(-70.9%) | -$3.69 B(+7.4%) |
| Dec 2020 | -$3.44 B(+99.2%) | -$1.94 B(+96.9%) | -$3.44 B(+73.0%) |
| Sept 2020 | - | -$985.15 M(+387.7%) | -$1.99 B(+46.4%) |
| June 2020 | - | -$201.98 M(-35.0%) | -$1.36 B(-13.9%) |
| Mar 2020 | - | -$310.91 M(-36.5%) | -$1.58 B(-8.7%) |
| Dec 2019 | -$1.73 B(-9.8%) | -$489.26 M(+37.8%) | -$1.73 B(-9.4%) |
| Sept 2019 | - | -$354.97 M(-15.7%) | -$1.91 B(-3.5%) |
| June 2019 | - | -$420.93 M(-8.6%) | -$1.98 B(+1.3%) |
| Mar 2019 | - | -$460.53 M(-31.2%) | -$1.95 B(+1.9%) |
| Dec 2018 | -$1.91 B(+91.3%) | -$668.98 M(+57.5%) | -$1.91 B(+12.2%) |
| Sept 2018 | - | -$424.66 M(+7.4%) | -$1.71 B(+5.9%) |
| June 2018 | - | -$395.27 M(-6.9%) | -$1.61 B(+21.5%) |
| Mar 2018 | - | -$424.64 M(-8.0%) | -$1.33 B(+32.5%) |
| Dec 2017 | -$1.00 B(-0.9%) | -$461.63 M(+40.3%) | -$1.00 B(+6.5%) |
| Sept 2017 | - | -$329.06 M(+198.1%) | -$939.19 M(-6.9%) |
| June 2017 | - | -$110.38 M(+11.3%) | -$1.01 B(+15.8%) |
| Mar 2017 | - | -$99.13 M(-75.3%) | -$870.94 M(-13.7%) |
| Dec 2016 | -$1.01 B(+11.2%) | -$400.61 M(+0.4%) | -$1.01 B(-22.8%) |
| Sept 2016 | - | -$398.83 M(-1543.0%) | -$1.31 B(-6.5%) |
| June 2016 | - | $27.64 M(-111.6%) | -$1.40 B(-1.8%) |
| Mar 2016 | - | -$237.45 M(-66.0%) | -$1.42 B(+56.9%) |
| Dec 2015 | -$907.22 M(+146.4%) | -$698.28 M(+42.5%) | -$907.22 M(+85.0%) |
| Sept 2015 | - | -$490.12 M(<-9900.0%) | -$490.48 M(+161.6%) |
| June 2015 | - | $2.19 M(-99.2%) | -$187.47 M(+13.3%) |
| Mar 2015 | - | $278.99 M(-199.1%) | -$165.51 M(-55.0%) |
| Dec 2014 | -$368.14 M(-25.4%) | -$281.54 M(+50.5%) | -$368.14 M(+104.4%) |
| Sept 2014 | - | -$187.12 M(-874.7%) | -$180.14 M(-48.4%) |
| June 2014 | - | $24.15 M(-68.4%) | -$348.92 M(+0.3%) |
| Mar 2014 | - | $76.37 M(-181.6%) | -$347.84 M(-29.6%) |
| Dec 2013 | -$493.76 M(-29.7%) | -$93.55 M(-73.7%) | -$493.76 M(-28.6%) |
| Sept 2013 | - | -$355.89 M(-1510.6%) | -$691.26 M(+9.7%) |
| June 2013 | - | $25.23 M(-136.3%) | -$630.28 M(+17.9%) |
| Mar 2013 | - | -$69.55 M(-76.1%) | -$534.54 M(-23.9%) |
| Dec 2012 | -$702.86 M | -$291.05 M(-1.3%) | -$702.86 M(-20.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$294.91 M(-343.8%) | -$882.14 M(+26.0%) |
| June 2012 | - | $120.97 M(-150.9%) | -$700.34 M(-19.0%) |
| Mar 2012 | - | -$237.87 M(-49.4%) | -$864.76 M(+33.8%) |
| Dec 2011 | -$646.16 M(-34.9%) | -$470.33 M(+315.8%) | -$646.16 M(-22.0%) |
| Sept 2011 | - | -$113.11 M(+160.3%) | -$827.89 M(-4.6%) |
| June 2011 | - | -$43.46 M(+125.6%) | -$867.50 M(-8.9%) |
| Mar 2011 | - | -$19.26 M(-97.0%) | -$952.61 M(-4.1%) |
| Dec 2010 | -$993.22 M(+74.2%) | -$652.06 M(+327.0%) | -$993.22 M(+79.6%) |
| Sept 2010 | - | -$152.72 M(+18.8%) | -$552.96 M(-1.8%) |
| June 2010 | - | -$128.56 M(+114.7%) | -$563.06 M(+4.6%) |
| Mar 2010 | - | -$59.87 M(-71.7%) | -$538.45 M(-5.5%) |
| Dec 2009 | -$570.06 M(+108.9%) | -$211.81 M(+30.1%) | -$570.06 M(+36.8%) |
| Sept 2009 | - | -$162.82 M(+56.6%) | -$416.86 M(+21.4%) |
| June 2009 | - | -$103.96 M(+13.6%) | -$343.26 M(+10.8%) |
| Mar 2009 | - | -$91.48 M(+56.1%) | -$309.92 M(+13.6%) |
| Dec 2008 | -$272.92 M(-2.3%) | -$58.61 M(-34.3%) | -$272.92 M(+47.6%) |
| Sept 2008 | - | -$89.22 M(+26.3%) | -$184.92 M(-12.9%) |
| June 2008 | - | -$70.62 M(+29.6%) | -$212.31 M(-16.8%) |
| Mar 2008 | - | -$54.47 M(-285.4%) | -$255.29 M(-8.6%) |
| Dec 2007 | -$279.31 M(-34.2%) | $29.39 M(-125.2%) | -$279.31 M(-36.3%) |
| Sept 2007 | - | -$116.60 M(+2.6%) | -$438.79 M(-6.0%) |
| June 2007 | - | -$113.60 M(+44.7%) | -$466.94 M(-3.5%) |
| Mar 2007 | - | -$78.50 M(-39.7%) | -$484.09 M(+14.1%) |
| Dec 2006 | -$424.44 M(-48.2%) | -$130.09 M(-10.1%) | -$424.44 M(-37.3%) |
| Sept 2006 | - | -$144.75 M(+10.7%) | -$677.18 M(-5.3%) |
| June 2006 | - | -$130.75 M(+593.5%) | -$714.87 M(+0.8%) |
| Mar 2006 | - | -$18.85 M(-95.1%) | -$709.38 M(-13.4%) |
| Dec 2005 | -$819.18 M(+143.2%) | -$382.83 M(+109.8%) | -$819.18 M(+27.9%) |
| Sept 2005 | - | -$182.44 M(+45.7%) | -$640.31 M(+5.9%) |
| June 2005 | - | -$125.25 M(-2.6%) | -$604.58 M(+9.0%) |
| Mar 2005 | - | -$128.66 M(-36.9%) | -$554.70 M(+64.7%) |
| Dec 2004 | -$336.85 M(-4.5%) | -$203.96 M(+39.0%) | -$336.85 M(+153.5%) |
| Sept 2004 | - | -$146.71 M(+94.7%) | -$132.89 M(-1061.8%) |
| June 2004 | - | -$75.37 M(-184.5%) | $13.82 M(-84.5%) |
| Mar 2004 | - | $89.19 M | $89.19 M |
| Dec 2003 | -$352.84 M(-36.7%) | - | - |
| Dec 2002 | -$557.51 M(+12.4%) | - | - |
| Dec 2001 | -$495.99 M(+57.4%) | - | - |
| Dec 2000 | -$315.16 M(+69.9%) | - | - |
| Dec 1999 | -$185.55 M(-28.6%) | - | - |
| Dec 1998 | -$259.88 M(-48.0%) | - | - |
| Dec 1997 | -$499.80 M(+72.3%) | - | - |
| Dec 1996 | -$290.06 M(+969.4%) | - | - |
| Dec 1995 | -$27.12 M(-92.4%) | - | - |
| Dec 1994 | -$355.36 M(-21.6%) | - | - |
| Dec 1993 | -$453.45 M(+14.4%) | - | - |
| Dec 1992 | -$396.48 M(+42.3%) | - | - |
| Dec 1991 | -$278.56 M(+0.5%) | - | - |
| Dec 1990 | -$277.15 M | - | - |
FAQ
- What is Novo Nordisk A/S annual cash flow from investing activities?
- What is the all time high annual CFI for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual CFI year-on-year change?
- What is Novo Nordisk A/S quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly CFI year-on-year change?
- What is Novo Nordisk A/S TTM cash flow from investing activities?
- What is the all time high TTM CFI for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM CFI year-on-year change?
What is Novo Nordisk A/S annual cash flow from investing activities?
The current annual CFI of NVO is -$6.37 B
What is the all time high annual CFI for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual cash flow from investing activities is -$27.12 M
What is Novo Nordisk A/S annual CFI year-on-year change?
Over the past year, NVO annual cash flow from investing activities has changed by -$2.84 B (-80.40%)
What is Novo Nordisk A/S quarterly cash flow from investing activities?
The current quarterly CFI of NVO is -$3.13 B
What is the all time high quarterly CFI for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly cash flow from investing activities is $576.22 M
What is Novo Nordisk A/S quarterly CFI year-on-year change?
Over the past year, NVO quarterly cash flow from investing activities has changed by -$1.20 B (-62.08%)
What is Novo Nordisk A/S TTM cash flow from investing activities?
The current TTM CFI of NVO is -$7.66 B
What is the all time high TTM CFI for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM cash flow from investing activities is $89.19 M
What is Novo Nordisk A/S TTM CFI year-on-year change?
Over the past year, NVO TTM cash flow from investing activities has changed by -$1.37 B (-21.77%)